Filament Health and ATMA Journey Centers Announce Licensing Agreement
ATMA will use Filament’s proprietary botanical drug candidate for clinical trials
Read moreMonth: February 2022
ATMA will use Filament’s proprietary botanical drug candidate for clinical trials
Read moreJoin our newsletter for the latest updates, insights, and exclusive offers on everything psychedelic therapy.
